Filing Details
- Accession Number:
- 0001209191-21-012320
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-19 16:05:48
- Reporting Period:
- 2021-02-17
- Accepted Time:
- 2021-02-19 16:05:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Global Research And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-17 | 6,240 | $211.75 | 46,858 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-02-18 | 1,079 | $210.11 | 45,779 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-18 | 4,513 | $211.84 | 41,266 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-18 | 2,033 | $212.59 | 39,233 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-18 | 200 | $213.26 | 39,033 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $210.11 (range $209.60 to $210.54).
- Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $211.84 (range $211.22 to $212.21).
- Open market sales reported on this line occurred at a weighted average price of $212.59 (range $212.22 to $213.00).
- Open market sales reported on this line occurred at a weighted average price of $213.26 (range $213.23 to $213.29).
Billionaire Hedge Funds
